{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:42:22Z","timestamp":1793889742049,"version":"4.8.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2018,1,15]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Attenuated Edmonston lineage measles virus (MV-Edm) vaccine strains can preferentially\ninfect and lyse a wide variety of cancer cells. Oncolytic MV-Edm derivatives are genetically\nengineered to express the human carcinoembryonic antigen (MV-CEA virus) or the human sodium\niodide symporter (MV-NIS virus) and are currently being tested in clinical trials against ovarian\ncancer, glioblastoma multiforme, multiple myeloma, mesothelioma, head and neck cancer, breast\ncancer and malignant peripheral nerve sheath tumors. This review describes the basic and preclinical\ndata that facilitated the clinical translation of MV-Edm strains, and summarizes the clinical results\nof this oncolytic platform to date. Furthermore, we discuss the latest clinically relevant MV-Edm\nvector developments and creative strategies for future translational steps.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568009617666170222125035","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T21:14:00Z","timestamp":1487884440000},"page":"177-187","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects"],"prefix":"10.2174","volume":"18","author":[{"given":"Pavlos","family":"Msaouel","sequence":"first","affiliation":[{"name":"MD Anderson Cancer Center, Division of Cancer Medicine, 1400 Holcombe Blvd, Unit 0463, Houston, TX 77030, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Opyrchal","sequence":"additional","affiliation":[{"name":"Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Whye","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Federspiel","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Galanis","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/150346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/150346\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/150346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:05:19Z","timestamp":1609257919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/150346\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009617666170222125035","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2016-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}